Volume 125, Issue 3 , Pages 611-616, March 2010
Inflammation and airway function in the lung periphery of patients with stable asthma
Background
An important role for exhaled nitric oxide (NO) measurement could be in the distinction between proximal and peripheral lung contributions to inflammation, with a particular interest for the alveolar lung zone and its implication on airway function.
Objective
We aimed to isolate the acinar lung zone contribution to both inflammation and airway function to seek a relationship between them.
Methods
In 30 patients with asthma with an asthma control test score exceeding 20, indices of conductive and acinar ventilation heterogeneity (Scond, Sacin) were obtained from a multiple breath washout. NO production in the conductive airways (J'awNO), alveolar NO concentration (CANO), and the standard exhaled NO at 50 mL/s (FENO50) were obtained from exhaled NO.
Results
Scond was consistently abnormal in all patients with stable asthma, but without any correlation to inflammation abnormality in that compartment (J'awNO). Sacin was particularly abnormal in the asthma subgroup receiving >500 μg budesonide equivalent, and a correlation was found between Sacin and CANO (r = 0.61; P = .015); in this subgroup, a weak association was found between Scond and J'awNO or FENO50 (r = 0.50; P = .059 for both).
Conclusion
The persistent functional abnormality of small conductive airways in patients with stable asthma is largely independent of inflammation as measured by exhaled NO. In the alveolar compartment, a functional correlate of alveolar NO was found in a subgroup of patients with stable asthma on moderate-to-high maintenance doses of inhaled steroids. These patients in particular could benefit from novel therapies specifically aimed at improving airway functionality at the level of the acinar entrance and beyond.
Key words: Small airways, exhaled nitric oxide, stable asthma, inflammation
Abbreviations used: ACT, Asthma control test, CANO, Alveolar nitric oxide concentration, CANOcorr1, Corrected alveolar nitric oxide concentration as proposed by Condorelli et al27, CANOcorr2, Corrected alveolar nitric oxide concentration as proposed by Kerckx et al28, FENO50, Fractional concentration of exhaled nitric oxide measured at expiratory flow rate of 50 mL/s, J'awNO, Nitric oxide flux in the conductive airways, NO, Nitric oxide, Sacin, Acinar ventilation heterogeneity, Scond, Conductive ventilation heterogeneity, Sn, Normalized N2 phase III slope in each expiration of a multiple breath N2 washout, TO, Lung turnover
Supported by the Fund for Scientific Research—Flanders and the NO Microgravity Application Project of the European Space Agency.
Disclosure of potential conflict of interest: S. Verbanck has received research support from the Fund for Scientific Research and the European Space Agency. The rest of the authors have declared that they have no conflict of interest.
PII: S0091-6749(09)01630-3
doi:10.1016/j.jaci.2009.10.053
© 2010 American Academy of Allergy, Asthma & Immunology. Published by Elsevier Inc. All rights reserved.
Volume 125, Issue 3 , Pages 611-616, March 2010
